Landiolol, a super‐short‐acting β‐blocker used in Europe and Japan during thoracic surgery to control heart rate, was associated with significantly lower postesophagectomy AF and lower IL‐6 levels.50 The gene discussed is IL6; the disease is atrial fibrillation.